ArticlePloS one2014

Intranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine model.

Veronica Tisato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.